Junmin Wang, Hongjiao Xiang, Yifei Lu, Tao Wu, Guang Ji. Biomed Pharmacother 2021
Times Cited: 3
Times Cited: 3
Times Cited
Times Co-cited
Similarity
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
100
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
George L Bakris, Rajiv Agarwal, Stefan D Anker, Bertram Pitt, Luis M Ruilope, Peter Rossing, Peter Kolkhof, Christina Nowack, Patrick Schloemer, Amer Joseph,[...]. N Engl J Med 2020
George L Bakris, Rajiv Agarwal, Stefan D Anker, Bertram Pitt, Luis M Ruilope, Peter Rossing, Peter Kolkhof, Christina Nowack, Patrick Schloemer, Amer Joseph,[...]. N Engl J Med 2020
66
Effects of Selonsertib in Patients with Diabetic Kidney Disease.
Glenn M Chertow, Pablo E Pergola, Fang Chen, Brian J Kirby, John S Sundy, Uptal D Patel. J Am Soc Nephrol 2019
Glenn M Chertow, Pablo E Pergola, Fang Chen, Brian J Kirby, John S Sundy, Uptal D Patel. J Am Soc Nephrol 2019
33
ASK1 Inhibitor Halts Progression of Diabetic Nephropathy in Nos3-Deficient Mice.
Greg H Tesch, Frank Y Ma, Yingjie Han, John T Liles, David G Breckenridge, David J Nikolic-Paterson. Diabetes 2015
Greg H Tesch, Frank Y Ma, Yingjie Han, John T Liles, David G Breckenridge, David J Nikolic-Paterson. Diabetes 2015
33
hs-CRP Is Associated With Incident Diabetic Nephropathy: Findings From the Jackson Heart Study.
Satyesh K Sinha, Susanne B Nicholas, Jung Hye Sung, Adolfo Correa, Tripathi B Rajavashisth, Keith C Norris, Jae Eun Lee. Diabetes Care 2019
Satyesh K Sinha, Susanne B Nicholas, Jung Hye Sung, Adolfo Correa, Tripathi B Rajavashisth, Keith C Norris, Jae Eun Lee. Diabetes Care 2019
33
Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease.
Jean-Philippe Bertocchio, David G Warnock, Frederic Jaisser. Kidney Int 2011
Jean-Philippe Bertocchio, David G Warnock, Frederic Jaisser. Kidney Int 2011
33
Macrophage accumulation in human progressive diabetic nephropathy.
Duy Nguyen, Fu Ping, Wei Mu, Prudence Hill, Robert C Atkins, Steven J Chadban. Nephrology (Carlton) 2006
Duy Nguyen, Fu Ping, Wei Mu, Prudence Hill, Robert C Atkins, Steven J Chadban. Nephrology (Carlton) 2006
33
Characterization of a coronary vasoconstrictor produced by cultured endothelial cells.
K A Hickey, G Rubanyi, R J Paul, R F Highsmith. Am J Physiol 1985
K A Hickey, G Rubanyi, R J Paul, R F Highsmith. Am J Physiol 1985
33
Glomerular hyperfiltration and renal disease progression in type 2 diabetes.
Piero Ruggenenti, Esteban L Porrini, Flavio Gaspari, Nicola Motterlini, Antonio Cannata, Fabiola Carrara, Claudia Cella, Silvia Ferrari, Nadia Stucchi, Aneliya Parvanova,[...]. Diabetes Care 2012
Piero Ruggenenti, Esteban L Porrini, Flavio Gaspari, Nicola Motterlini, Antonio Cannata, Fabiola Carrara, Claudia Cella, Silvia Ferrari, Nadia Stucchi, Aneliya Parvanova,[...]. Diabetes Care 2012
33
Mechanisms of Regulation of the Chemokine-Receptor Network.
Martin J Stone, Jenni A Hayward, Cheng Huang, Zil E Huma, Julie Sanchez. Int J Mol Sci 2017
Martin J Stone, Jenni A Hayward, Cheng Huang, Zil E Huma, Julie Sanchez. Int J Mol Sci 2017
33
Renal protective effect of SGLT2 inhibitor dapagliflozin alone and in combination with irbesartan in a rat model of diabetic nephropathy.
Ali F Abdel-Wahab, Ghazi A Bamagous, Randa M Al-Harizy, Naser A ElSawy, Naiyer Shahzad, Ibrahim A Ibrahim, Saeed S Al Ghamdi. Biomed Pharmacother 2018
Ali F Abdel-Wahab, Ghazi A Bamagous, Randa M Al-Harizy, Naser A ElSawy, Naiyer Shahzad, Ibrahim A Ibrahim, Saeed S Al Ghamdi. Biomed Pharmacother 2018
33
Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1.
M Saitoh, H Nishitoh, M Fujii, K Takeda, K Tobiume, Y Sawada, M Kawabata, K Miyazono, H Ichijo. EMBO J 1998
M Saitoh, H Nishitoh, M Fujii, K Takeda, K Tobiume, Y Sawada, M Kawabata, K Miyazono, H Ichijo. EMBO J 1998
33
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.
Dick de Zeeuw, Tadao Akizawa, Paul Audhya, George L Bakris, Melanie Chin, Heidi Christ-Schmidt, Angie Goldsberry, Mark Houser, Melissa Krauth, Hiddo J Lambers Heerspink,[...]. N Engl J Med 2013
Dick de Zeeuw, Tadao Akizawa, Paul Audhya, George L Bakris, Melanie Chin, Heidi Christ-Schmidt, Angie Goldsberry, Mark Houser, Melissa Krauth, Hiddo J Lambers Heerspink,[...]. N Engl J Med 2013
33
Role of the JAK/STAT signaling pathway in diabetic nephropathy.
Mario B Marrero, Amy K Banes-Berceli, David M Stern, Douglas C Eaton. Am J Physiol Renal Physiol 2006
Mario B Marrero, Amy K Banes-Berceli, David M Stern, Douglas C Eaton. Am J Physiol Renal Physiol 2006
33
Avosentan for overt diabetic nephropathy.
Johannes F E Mann, Damian Green, Kenneth Jamerson, Luis M Ruilope, Susan J Kuranoff, Thomas Littke, Giancarlo Viberti. J Am Soc Nephrol 2010
Johannes F E Mann, Damian Green, Kenneth Jamerson, Luis M Ruilope, Susan J Kuranoff, Thomas Littke, Giancarlo Viberti. J Am Soc Nephrol 2010
33
BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway.
Sambasiva Rao Kolati, Eshvendar Reddy Kasala, Lakshmi Narendra Bodduluru, Jalandhar Reddy Mahareddy, Shravan Kumar Uppulapu, Ranadeep Gogoi, Chandana C Barua, Mangala Lahkar. Environ Toxicol Pharmacol 2015
Sambasiva Rao Kolati, Eshvendar Reddy Kasala, Lakshmi Narendra Bodduluru, Jalandhar Reddy Mahareddy, Shravan Kumar Uppulapu, Ranadeep Gogoi, Chandana C Barua, Mangala Lahkar. Environ Toxicol Pharmacol 2015
33
Stromal cell-derived factor-1 is upregulated by dipeptidyl peptidase-4 inhibition and has protective roles in progressive diabetic nephropathy.
Satoru Takashima, Hiroki Fujita, Hiromi Fujishima, Tatsunori Shimizu, Takehiro Sato, Tsukasa Morii, Katsushi Tsukiyama, Takuma Narita, Takamune Takahashi, Daniel J Drucker,[...]. Kidney Int 2016
Satoru Takashima, Hiroki Fujita, Hiromi Fujishima, Tatsunori Shimizu, Takehiro Sato, Tsukasa Morii, Katsushi Tsukiyama, Takuma Narita, Takamune Takahashi, Daniel J Drucker,[...]. Kidney Int 2016
33
Origin and evolution of adaptive immunity.
Thomas Boehm, Jeremy B Swann. Annu Rev Anim Biosci 2014
Thomas Boehm, Jeremy B Swann. Annu Rev Anim Biosci 2014
33
Pentoxifylline diminishes the oxidative damage to renal tissue induced by streptozotocin in the rat.
M E Dávila-Esqueda, F Martínez-Morales. Exp Diabesity Res 2004
M E Dávila-Esqueda, F Martínez-Morales. Exp Diabesity Res 2004
33
Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice.
Rita E Mirza, Milie M Fang, Eileen M Weinheimer-Haus, William J Ennis, Timothy J Koh. Diabetes 2014
Rita E Mirza, Milie M Fang, Eileen M Weinheimer-Haus, William J Ennis, Timothy J Koh. Diabetes 2014
33
Predictive impact of elevated serum level of IL-18 for early renal dysfunction in type 2 diabetes: an observational follow-up study.
S Araki, M Haneda, D Koya, T Sugimoto, K Isshiki, M Chin-Kanasaki, T Uzu, A Kashiwagi. Diabetologia 2007
S Araki, M Haneda, D Koya, T Sugimoto, K Isshiki, M Chin-Kanasaki, T Uzu, A Kashiwagi. Diabetologia 2007
33
Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease.
Lynda A O'Sullivan, Clifford Liongue, Rowena S Lewis, Sarah E M Stephenson, Alister C Ward. Mol Immunol 2007
Lynda A O'Sullivan, Clifford Liongue, Rowena S Lewis, Sarah E M Stephenson, Alister C Ward. Mol Immunol 2007
33
Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species.
Makoto Kobayashi, Masayuki Yamamoto. Adv Enzyme Regul 2006
Makoto Kobayashi, Masayuki Yamamoto. Adv Enzyme Regul 2006
33
Endothelin Blockade in Diabetic Kidney Disease.
Lidia Anguiano, Marta Riera, Julio Pascual, María José Soler. J Clin Med 2015
Lidia Anguiano, Marta Riera, Julio Pascual, María José Soler. J Clin Med 2015
33
Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade.
Maria Vanessa Perez-Gomez, Maria Dolores Sanchez-Niño, Ana Belen Sanz, Catalina Martín-Cleary, Marta Ruiz-Ortega, Jesus Egido, Juan F Navarro-González, Alberto Ortiz, Beatriz Fernandez-Fernandez. J Clin Med 2015
Maria Vanessa Perez-Gomez, Maria Dolores Sanchez-Niño, Ana Belen Sanz, Catalina Martín-Cleary, Marta Ruiz-Ortega, Jesus Egido, Juan F Navarro-González, Alberto Ortiz, Beatriz Fernandez-Fernandez. J Clin Med 2015
33
The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential.
Hiroki Fujita, Tsukasa Morii, Hiromi Fujishima, Takehiro Sato, Tatsunori Shimizu, Mihoko Hosoba, Katsushi Tsukiyama, Takuma Narita, Takamune Takahashi, Daniel J Drucker,[...]. Kidney Int 2014
Hiroki Fujita, Tsukasa Morii, Hiromi Fujishima, Takehiro Sato, Tatsunori Shimizu, Mihoko Hosoba, Katsushi Tsukiyama, Takuma Narita, Takamune Takahashi, Daniel J Drucker,[...]. Kidney Int 2014
33
Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes.
J Lin, F B Hu, C Mantzoros, G C Curhan. Diabetologia 2010
J Lin, F B Hu, C Mantzoros, G C Curhan. Diabetologia 2010
33
Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice.
F Y Chow, D J Nikolic-Paterson, E Ozols, R C Atkins, B J Rollin, G H Tesch. Kidney Int 2006
F Y Chow, D J Nikolic-Paterson, E Ozols, R C Atkins, B J Rollin, G H Tesch. Kidney Int 2006
33
SGLT2is and Renal Protection: From Biological Mechanisms to Real-World Clinical Benefits.
Giovanna Leoncini, Elisa Russo, Elisabetta Bussalino, Cecilia Barnini, Francesca Viazzi, Roberto Pontremoli. Int J Mol Sci 2021
Giovanna Leoncini, Elisa Russo, Elisabetta Bussalino, Cecilia Barnini, Francesca Viazzi, Roberto Pontremoli. Int J Mol Sci 2021
33
Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARγ, and HO-1.
Qing Qing Wu, Yanxia Wang, Martin Senitko, Colin Meyer, W Christian Wigley, Deborah A Ferguson, Eric Grossman, Jianlin Chen, Xin J Zhou, John Hartono,[...]. Am J Physiol Renal Physiol 2011
Qing Qing Wu, Yanxia Wang, Martin Senitko, Colin Meyer, W Christian Wigley, Deborah A Ferguson, Eric Grossman, Jianlin Chen, Xin J Zhou, John Hartono,[...]. Am J Physiol Renal Physiol 2011
33
Relationship Between Atrasentan Concentrations and Urinary Albumin to Creatinine Ratio in Western and Japanese Patients With Diabetic Nephropathy.
Chih-Wei Lin, Nael M Mostafa, Dennis L Andress, John J Brennan, Cheri E Klein, Walid M Awni. Clin Ther 2018
Chih-Wei Lin, Nael M Mostafa, Dennis L Andress, John J Brennan, Cheri E Klein, Walid M Awni. Clin Ther 2018
33
Effect of PF-04634817, an Oral CCR2/5 Chemokine Receptor Antagonist, on Albuminuria in Adults with Overt Diabetic Nephropathy.
Jeremy D Gale, Steven Gilbert, Samuel Blumenthal, Tom Elliott, Pablo E Pergola, Kosalaram Goteti, Wim Scheele, Christelle Perros-Huguet. Kidney Int Rep 2018
Jeremy D Gale, Steven Gilbert, Samuel Blumenthal, Tom Elliott, Pablo E Pergola, Kosalaram Goteti, Wim Scheele, Christelle Perros-Huguet. Kidney Int Rep 2018
33
Cyclic nucleotide phosphodiesterases: relating structure and function.
S H Francis, I V Turko, J D Corbin. Prog Nucleic Acid Res Mol Biol 2001
S H Francis, I V Turko, J D Corbin. Prog Nucleic Acid Res Mol Biol 2001
33
New insights from SONAR indicate adding sodium glucose co-transporter 2 inhibitors to an endothelin receptor antagonist mitigates fluid retention and enhances albuminuria reduction.
Hiddo J L Heerspink, Donald E Kohan, Dick de Zeeuw. Kidney Int 2021
Hiddo J L Heerspink, Donald E Kohan, Dick de Zeeuw. Kidney Int 2021
33
Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy.
Celine C Berthier, Hongyu Zhang, MaryLee Schin, Anna Henger, Robert G Nelson, Berne Yee, Anissa Boucherot, Matthias A Neusser, Clemens D Cohen, Christin Carter-Su,[...]. Diabetes 2009
Celine C Berthier, Hongyu Zhang, MaryLee Schin, Anna Henger, Robert G Nelson, Berne Yee, Anissa Boucherot, Matthias A Neusser, Clemens D Cohen, Christin Carter-Su,[...]. Diabetes 2009
33
Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
Wu Song, Lin Wei, Yanwei Du, Yimei Wang, Shuang Jiang. Int Immunopharmacol 2018
Wu Song, Lin Wei, Yanwei Du, Yimei Wang, Shuang Jiang. Int Immunopharmacol 2018
33
Analogs of bardoxolone methyl worsen diabetic nephropathy in rats with additional adverse effects.
Carla Zoja, Daniela Corna, Valeria Nava, Monica Locatelli, Mauro Abbate, Flavio Gaspari, Fabiola Carrara, Fabio Sangalli, Giuseppe Remuzzi, Ariela Benigni. Am J Physiol Renal Physiol 2013
Carla Zoja, Daniela Corna, Valeria Nava, Monica Locatelli, Mauro Abbate, Flavio Gaspari, Fabiola Carrara, Fabio Sangalli, Giuseppe Remuzzi, Ariela Benigni. Am J Physiol Renal Physiol 2013
33
Efficacy and safety of endothelin receptor antagonists in type 2 diabetic kidney disease: A systematic review and meta-analysis of randomized controlled trials.
Y Zhou, J Chi, Y Huang, B Dong, W Lv, Y G Wang. Diabet Med 2021
Y Zhou, J Chi, Y Huang, B Dong, W Lv, Y G Wang. Diabet Med 2021
33
Liraglutide ameliorates renal injury in streptozotocin‑induced diabetic rats by activating endothelial nitric oxide synthase activity via the downregulation of the nuclear factor‑κB pathway.
Sai-Jun Zhou, Lian Bai, Lin Lv, Rui Chen, Chun-Jun Li, Xiang-Yang Liu, De-Min Yu, Pei Yu. Mol Med Rep 2014
Sai-Jun Zhou, Lian Bai, Lin Lv, Rui Chen, Chun-Jun Li, Xiang-Yang Liu, De-Min Yu, Pei Yu. Mol Med Rep 2014
33
The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis.
Brendan B McCormick, Amy Sydor, Ayub Akbari, Dean Fergusson, Steve Doucette, Greg Knoll. Am J Kidney Dis 2008
Brendan B McCormick, Amy Sydor, Ayub Akbari, Dean Fergusson, Steve Doucette, Greg Knoll. Am J Kidney Dis 2008
33
Endothelin and endothelin antagonists in chronic kidney disease.
Donald E Kohan, Matthias Barton. Kidney Int 2014
Donald E Kohan, Matthias Barton. Kidney Int 2014
33
33
Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study.
A Festa, R D'Agostino, G Howard, L Mykkänen, R P Tracy, S M Haffner. Kidney Int 2000
A Festa, R D'Agostino, G Howard, L Mykkänen, R P Tracy, S M Haffner. Kidney Int 2000
33
30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development.
Peter Kolkhof, Lars Bärfacker. J Endocrinol 2017
Peter Kolkhof, Lars Bärfacker. J Endocrinol 2017
33
A First-in-Patient, Multicenter, Double-Blind, 2-Arm, Placebo-Controlled, Randomized Safety and Tolerability Study of a Novel Oral Drug Candidate, CTP-499, in Chronic Kidney Disease.
LuAnn Sabounjian, Philip Graham, Lijun Wu, Virginia Braman, Changfu Cheng, Julie Liu, James Shipley, Joel Neutel, Michael Dao. Clin Pharmacol Drug Dev 2016
LuAnn Sabounjian, Philip Graham, Lijun Wu, Virginia Braman, Changfu Cheng, Julie Liu, James Shipley, Joel Neutel, Michael Dao. Clin Pharmacol Drug Dev 2016
33
Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects with Overt Diabetic Nephropathy.
Wim Scheele, Susan Diamond, Jeremy Gale, Valerie Clerin, Nihad Tamimi, Vu Le, Rosalind Walley, Fernando Grover-Páez, Christelle Perros-Huguet, Timothy Rolph,[...]. J Am Soc Nephrol 2016
Wim Scheele, Susan Diamond, Jeremy Gale, Valerie Clerin, Nihad Tamimi, Vu Le, Rosalind Walley, Fernando Grover-Páez, Christelle Perros-Huguet, Timothy Rolph,[...]. J Am Soc Nephrol 2016
33
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control.
Martin R Cowie, Miles Fisher. Nat Rev Cardiol 2020
Martin R Cowie, Miles Fisher. Nat Rev Cardiol 2020
33
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
George L Bakris, Rajiv Agarwal, Stefan D Anker, Bertram Pitt, Luis M Ruilope, Christina Nowack, Peter Kolkhof, Anna C Ferreira, Patrick Schloemer, Gerasimos Filippatos. Am J Nephrol 2019
George L Bakris, Rajiv Agarwal, Stefan D Anker, Bertram Pitt, Luis M Ruilope, Christina Nowack, Peter Kolkhof, Anna C Ferreira, Patrick Schloemer, Gerasimos Filippatos. Am J Nephrol 2019
33
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.